UID
653610
�Ķ�Ȩ��
20
רҵ��
����
��ҽ��
�ʻ�
ע��ʱ��
2008-4-4
|
θʳ�ܷ�����8������
����ʹ�á�
(2)���õ��ܿճ�Roux-en-Y�ǽ�����������.�ɸ�
��θ�ճ��ǽ�.�Խ����Ԥ��}һ��ָ�����衣��ȥ������
���ȹܹ�����ɵĸ�ʹ������������ڹ����ϰ������е�
����θ���ǽ��ͬʱ.�����ȹܿճ��ǽ�.�ɽ���ȹܸ�ѹ
��ɵ���ʹ.��������ڹ���С���״�����������ơ�
(3)�����ھ��ͽ��뼼���ķ�չ��ͨ���ھ����õ���
��֧��.�ȹ���֧�ܺͳ�����֧��.�Լ���ǻ�������ǽ顢
θ���ǽ�Ⱥ��ν����ͷ�����˵Ļƾҡ�lһ��ָ�������
֢״.�Ѿ��õ�Խ��Խ���Ӧ�á�
3. 5�۽�����
3. 5. 1���ƺͷ������ٰ���ǰ�������ƻ��ſ�)����
��Ȼ��������.��5һFCT���.��������(G}ncitabine)��
����������������������ơ����Ӱ���ҩ�����Ч������
����
���ư�����ǰ���ơ����з��ơ����ε�ǿ���ơ�������
�������������ƺͷŻ��ơ�
3. 5. 2�����������ư�����Ƶ��֯���䶳�����ܾ�
��������Y�м��������Ƶ�.Ŀǰ��û����ȷ֤����ʾ����
���ӳ������ڡ�
���ٰ���Ϻ��������̼�ͼto
2003, 6 ( 5):349һ35&
Aganval B, Abu-Hamda E,Molke KL et al Endoscopic ultra-
Fund-guided fine needle a}imtion and multidetechm }iml CT
in the diagnosis of pancreatic cancer[J].Am J Gashoenterol,
2004,99(5):844һ850.
Haln U, Schumann T, Schie&e 1, et al Decrease of CA 19-9
during chemotherapy with gemcitabine predicts survival tine in
patients with advanced pancreatic cancer[J].B r J Cancer,
2000,82(5):1013һIOIG
LiD, Xie K,Wo1ffR, et al Pancreatic cancer[J].Lancet, 2004,
363(9414):1049һ1057.
Pisters Pv\��Hudec WA, Hess KR��et al Effect of preoperative
biliary decanpression on pancreaticoduodenectmorbidity in 300 consecutive patients[J].Ann Surg, 2001, 234
(1):47һ55.
Tseng JF, Raut CP, Lee JE, et al Pancreaticoduodenechnny with
vascular resection: margin status and survival duration[J].J
Gastrointest Surg, 2004, 8 ( 8):93sһ949; discussion 949һ950.
Pisters P, Brennan M. Regonal lymph node dissection for pan-
creaticadenocarcinoma In: EvansD, PistersP, AbbmzzeseJ,
eds Pancreatic Cancer[M].New York:ӡringer V erlag, 2002:
139һ151.
��Σ��Ⱥ.....~����ɫͨ���IJ�~~~~~-�������
��ȫ����ذһ=ʾ
������־����
Ӱ��ѧ���
��֯������
��һһһ��ʬһһһһһ����
{
ȷ�����
�ų����
��
�����..~���������
��
����������
һ��һ
�ۺ�����....��
...�в������г�
��һ
��Ϣ����
һ��
��...~�š�����
ͼ1���ٰ���������
�����
f21
[31
Jemal A, Siegel R, Ward E, et al Cancer statistics[J].CA
Cancer) C1in,2006,56(2):IOGһ130.
Patel AV, Rodriguez C, Bemstein L, et al Obesity, recreational
physical activity, and risk of pancreatic cancer in a large U. S
Cohort[ J].Cancer Epideme}l Bianarkers Prev, 2005, 14 (2):
459һ4GG
Pongpra}bchai S, Chari ST Managementof Patients atH igh R isk
for Pancreatic Cancer[J].Curr Treat Options Gastroenterol,
[4]
[5]
[G]
f}]
[s]
[9]
[10]
[11]
[12]
[13]
[14]
[IS]
[IG }
Henne��mns D, Vogel 1, Luttges J, et al Surgery for ductal
adenocarcinomaofthepancreatichead: staging, canplications,
and survival after regional versus extended lymphadenectcxny
[J].Wor1dJ Surg, 2000,24(5):595һG01.
Gouma DJ, van Geenen RC, van Gulik }��et al Rates of
canplications and death after pancreasticoduoһden echnn y:
risk fachms and the inpact of ho}ihl volume[J].Ann Surg,
2000,232 (G):78Gһ795.
Neoph}lemos JP, Sh}cken DD, Friess H, et al European Study
Group for Pancreatic Cancer A random ized trial of chemoradio-
therapy and chemotherapy after resecte}n of pancreatic cancer
[J].N Eng1 J Med, 2004, 350 (12):1200һ1210.
KoshyMC, Landry JC, Cavanaugh SX, et al A challenge h} the
therapeutic nihilisn of ESPACһ1[J].IntJ RadiatOncolBiol
Phys,2005,61(4):9G5һ96G
Neuhuas P, Oettle H, Post S A random ized, projective, multi-
center, phase��trial of adjuvant chemotherapy with gemcit-
abine vs observation in patientswith resected pancreatic cancer
[J].J Clin Oncol (meeting Abstracts)��2005, 23: LBA4013.
Moore Al\��Cardenes H, Johnron CS, et al A phase II study of
gemcitabine in canbination with mdiate}n therapy in patients
with bcalized, unresectable, pancreatic cancer a HoosierOncol-
ogy Group Trial (abstract). ASCO AnnualMeeting Proceedings
(post-meeting edition) [J].J Clin Oncol, 2004, 22: 4105.
Polbck RE, Dorosh}v JH, Khayat D, et al UICC Manual of
clinical oncobgy[M].2004 by John W iley&Sons, Inc
(2007һ08һ08I}X��) |
|
������ 2010-4-26 21:10
�ղ�
����
����
֧��
